Stay updated on Menin Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.

Latest updates to the Menin Inhibitor Combo in AML Clinical Trial page
- Check5 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, preventing access to the study details. This appears to be a site-access issue rather than an update to the study information.SummaryDifference18%

- Check26 days agoChange DetectedThe contact information heading capitalization was standardized, and the site revision label was updated from v3.6.6 to v3.7.0, reflecting a newer build.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision label in the page footer updated to v3.6.6 (replacing v3.6.5). This signals a site version update without changes to the study information.SummaryDifference0.1%

- Check47 days agoChange DetectedThe changes reflect updates to the page's revision history with new and prior update dates, indicating administrative updates rather than alterations to the study details.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new page build. This appears to be a minor maintenance update rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to Menin Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.